Gardner Lewis Asset Management L P Chimerix Inc Call Options Transaction History

Gardner Lewis Asset Management L P

  • $415 Million
  • Q1 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $748M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email